SFM
BSX icon

Systematic Financial Management’s Boston Scientific BSX Stock Holding History

Systematic Financial Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-16,250
Closed -$624K – 625
2019
Q1 		$624K Buy
16,250
+6,000
+59% +$229K 0.02% 552
2018
Q4 		$362K Sell
10,250
-1,700
-14% -$61.7K 0.01% 583
2018
Q3 		$460K Sell
11,950
-5,050
-30% -$176K 0.01% 606
2018
Q2 		$556K Sell
17,000
-1,000
-6% -$30.2K 0.01% 576
2018
Q1 		$492K Buy
18,000
+6,100
+51% +$166K 0.01% 581
2017
Q4 		$295K Sell
11,900
-458,320
-97% -$12.6M 0.01% 612
2017
Q3 		$13.7M Sell
470,220
-72,905
-13% -$2.01M 0.28% 113
2017
Q2 		$15.1M Sell
543,125
-138,023
-20% -$3.66M 0.28% 112
2017
Q1 		$16.9M Sell
681,148
-441,790
-39% -$10.7M 0.3% 100
2016
Q4 		$24.3M Sell
1,122,938
-300,846
-21% -$6.56M 0.39% 72
2016
Q3 		$33.9M Sell
1,423,784
-1,331,535
-48% -$31.8M 0.48% 65
2016
Q2 		$64.4M Sell
2,755,319
-304,952
-10% -$6.6M 0.88% 30
2016
Q1 		$57.6M Sell
3,060,271
-598,833
-16% -$10.5M 0.72% 41
2015
Q4 		$67.5M Buy
3,659,104
+167,539
+5% +$3M 0.74% 44
2015
Q3 		$57.3M Buy
3,491,565
+477,900
+16% +$8.17M 0.61% 49
2015
Q2 		$53.3M Sell
3,013,665
-303,924
-9% -$5.43M 0.46% 66
2015
Q1 		$58.9M Sell
3,317,589
-2,641,656
-44% -$41.7M 0.47% 72
2014
Q4 		$79M Buy
5,959,245
+4,340,509
+268% +$55.5M 0.58% 55
2014
Q3 		$19.1M Sell
1,618,736
-45,493
-3% -$573K 0.14% 158
2014
Q2 		$21.3M Sell
1,664,229
-348,017
-17% -$4.53M 0.15% 160
2014
Q1 		$27.2M Sell
2,012,246
-3,250,199
-62% -$42.7M 0.19% 135
2013
Q4 		$63.3M Sell
5,262,445
-45,457
-0.9% -$537K 0.46% 69
2013
Q3 		$62.3M Sell
5,307,902
-1,399,669
-21% -$15.1M 0.49% 72
2013
Q2 		$62.2M Buy
+6,707,571
New +$56.9M 0.53% 60

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Systematic Financial Management's BSX Position: Q2 2019 in Review

Systematic Financial Management sold out of Boston Scientific (BSX) in Q2 2019, closing a stake of 16,250 shares — an estimated $624K sold.

Systematic Financial Management first reported a position in BSX in Q2 2013 and held it in 24 quarters. The position peaked at $79M in Q4 2014. 757 funds tracked by Wall St. Rank hold BSX as of Q2 2019.

  • Systematic Financial Management reported no remaining Boston Scientific position as of Q2 2019 after selling out during the quarter.
  • Systematic Financial Management sold 16,250 Boston Scientific shares in Q2 2019, an estimated $624K.
  • Systematic Financial Management first reported a position in Boston Scientific in Q2 2013 and held it in 24 quarters.
  • Systematic Financial Management's Boston Scientific position peaked at $79M in Q4 2014.
  • 757 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2019.

Based on Systematic Financial Management's 13F filing for Q2 2019, filed 26 Jul 2019.